Assess Ontario's school-based human papillomavirus (HPV) vaccination program on
reducing rates of cervical dysplasia, colposcopy services and treatment for genital warts …

The impact of human papillomavirus (HPV) vaccination on cervical screening, colposcopy,
and treatment is incompletely understood. In 2004–2005, investigators in the Costa Rica …

Objectives The aims of the study are to examine the perception of the human papillomavirus
(HPV) vaccine among those with and without a history of cervical dysplasia and to examine …

Background Human papillomavirus (HPV)–related disease remains a significant source of
morbidity and mortality, and this underscores the need to increase HPV vaccination to …

Introduction Demonstrating human papillomavirus vaccine impact is critical for informing
guidelines to increase vaccination and decrease human papillomavirus‒related outcomes …

Background The impact of the prophylactic vaccine against human papillomavirus (HPV)
types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was …

Background: A school-based program with quadrivalent human papillomavirus (HPV)
vaccination was implemented in Alberta in 2008. We assessed the impact of this program on …

Cervical cancer prevention guidelines are benchmarked to risk of cervical precancer. In
younger age cohorts, vaccination against high-risk types of human papillomavirus (HPV) …

The effectiveness of a vaccination program is influenced by its design and implementation
details and by the target population characteristics. Using routinely collected population …

It has been clearly established that sexually transmitted human papillomavirus (HPV)
infections are the major cause of genital warts and cervical cancer and are a contributing …